UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma

Nature communications, 2019-11, Vol.10 (1), p.5440-7, Article 5440

2019

Volltextzugriff (PDF)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

Oncoimmunology, 2022, Vol.11 (1), p.2066767-2066767

2022

Volltextzugriff (PDF)

Rates of Internal Hiring of Ophthalmology Faculty from their Institution of Training at Top Academic Medical Centers: A Cross-Sectional Study

Journal of academic ophthalmology (2017), 2023-07, Vol.15 (2), p.e154-e161

2023

Volltextzugriff (PDF)

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer research (Chicago, Ill.), 2020-03, Vol.80 (5), p.1078-1087

2020

Volltextzugriff (PDF)

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Scientific reports, 2021-02, Vol.11 (1), p.2809-2809, Article 2809

2021

Volltextzugriff (PDF)

Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma

Cancer Immunology, Immunotherapy, 2022-08, Vol.71 (8), p.1837-1849

2022

Volltextzugriff (PDF)

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Clinical cancer research, 2019-04, Vol.25 (8), p.2494-2502

2019

Volltextzugriff (PDF)

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma

American journal of clinical dermatology, 2020-02, Vol.21 (1), p.1-11

2020

Volltextzugriff (PDF)

Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy

Hematology/oncology clinics of North America, 2019-04, Vol.33 (2), p.291-299

2019

Volltextzugriff (PDF)

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

Melanoma research, 2020-08, Vol.30 (4), p.410

2020

Volltextzugriff (PDF)

The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-10, Vol.20 (10), p.80-14, Article 80

2018

Volltextzugriff (PDF)

FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab

Clinical nuclear medicine, 2020-04, Vol.45 (4), p.267

2020

Volltextzugriff (PDF)

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-12, Vol.20 (12), p.100-100, Article 100

2018

Volltextzugriff (PDF)

Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death

Clinical cancer research, 2020-03, Vol.26 (5), p.1126-1134

2020

Volltextzugriff (PDF)

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2798-2798

2019

Volltextzugriff (PDF)

Abstract B11: Prognostic biomarkers in stage II-III melanoma

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.B11-B11

2020

Volltextzugriff (PDF)

Prediction of distant melanoma recurrence from primary tumor digital H&E images using deep learning

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9577-9577

2019

Volltextzugriff (PDF)

Nivolumab for hepatocellular carcinoma (HCC) in a real-world context

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15675-e15675

2019

Volltextzugriff (PDF)

Effect of automated TIL quantification in early-stage melanoma on accuracy of standard T staging using AJCC guidelines

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.10076-10076

2020

Volltextzugriff (PDF)

Combination immunotherapy including OncoVEX mGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma

Cancer immunology, immunotherapy, 2022-08, Vol.71 (8), p.1837

2022

Volltextzugriff (PDF)

Future directions

Hematology/oncology clinics of North America, 2018, Vol.33 (2), p.291-299

2018

Volltextzugriff (PDF)

Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders

Scientific reports, 2021-04, Vol.11 (1), p.8775-8775, Article 8775

2021

Volltextzugriff (PDF)

Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21610-e21610

2018

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)
Berichte
(1)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

Rates of Internal Hiring of Ophthalmology Faculty from their Institution of Training at Top Academic Medical Centers: A Cross-Sectional Study

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma

Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy

Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

The Role of Oncolytic Viruses in the Treatment of Melanoma

FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Abstract B11: Prognostic biomarkers in stage II-III melanoma

Prediction of distant melanoma recurrence from primary tumor digital H&E images using deep learning

Nivolumab for hepatocellular carcinoma (HCC) in a real-world context

Effect of automated TIL quantification in early-stage melanoma on accuracy of standard T staging using AJCC guidelines

Combination immunotherapy including OncoVEX mGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma

Future directions

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders

Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma

Suchergebnisse filtern